Buprenorphine/naloxone (Suboxone, Zubsolv) Prescribers in Alaska
Ranked by documented Medicare Part D claim volume (2024).
76 providers in Alaska have Medicare Part D claims for buprenorphine/naloxone. Ordering reflects documented Part D claim volume — a transparency signal, not a quality or "best" ranking. Open any provider for their full profile and what they prescribe under Medicare.
buprenorphine/naloxone prescribers in Alaska
- 1View profile →
- 2View profile →
- 3View profile →
- 4View profile →
- 5View profile →
- 6View profile →
- 7View profile →
- 8View profile →
- 9View profile →
- 10View profile →
- 11View profile →
- 12View profile →
- 13View profile →
- 14View profile →
- 15View profile →
Addiction Medicine (Family Medicine) Physician · Ninilchik, AK
60 Medicare Part D claims (2024)
- 16View profile →
- 17View profile →
- 18View profile →
- 19View profile →
- 20View profile →
- 21View profile →
- 22View profile →James PriceD.O.
Pain Medicine (Anesthesiology) Physician · Palmer, AK
31 Medicare Part D claims (2024)
- 23View profile →
- 24View profile →
- 25View profile →
- 26View profile →
- 27View profile →
- 28View profile →
- 29View profile →
- 30View profile →
- 31View profile →
- 32View profile →
- 33View profile →
- 34View profile →
- 35View profile →
- 36View profile →
- 37View profile →
- 38View profile →
- 39View profile →
- 40View profile →
- 41View profile →
- 42View profile →Kristerra YaweaDNP, APRN, PMHNP, BC
Psychiatric/Mental Health Nurse Practitioner · Anchorage, AK
16 Medicare Part D claims (2024)
- 43View profile →
- 44View profile →
- 45View profile →
- 46View profile →
- 47View profile →
- 48View profile →
- 49View profile →
- 50View profile →
Medicare Part D only. Counts and ordering reflect Medicare Part D claims (2024) from CMS — they exclude cash-pay, commercial, and Medicaid prescriptions and undercount cash-pay categories (e.g. GLP-1 weight-loss, testosterone). Not a quality or "best" ranking. Absence does not mean a provider does not prescribe buprenorphine/naloxone. buprenorphine/naloxone is a Schedule III controlled substance; this is a factual claims directory only — not medical advice, not an endorsement, and not instructions for obtaining any medication. Source: CMS NPPES (June 2026).